2021 Q4 Form 10-Q Financial Statement

#000143774921025473 Filed on November 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $204.8K $173.5K $160.8K
YoY Change 44.23% 7.9% -29.56%
Cost Of Revenue $14.97K $15.52K $6.090K
YoY Change 97.49% 154.84% -79.75%
Gross Profit $189.9K $158.0K $154.8K
YoY Change 41.23% 2.12% -21.95%
Gross Profit Margin 92.69% 91.06% 96.21%
Selling, General & Admin $259.0K $141.1K $121.4K
YoY Change 75.51% 16.23% -15.2%
% of Gross Profit 136.44% 89.31% 78.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $540.00 $507.00 $1.326K
YoY Change -32.5% -61.76% 161.54%
% of Gross Profit 0.28% 0.32% 0.86%
Operating Expenses $259.5K $141.7K $122.8K
YoY Change 75.25% 15.4% -14.58%
Operating Profit -$69.69K $277.7K $73.33K
YoY Change 409.8% 278.69% 34.4%
Interest Expense $2.550K $3.620K $6.910K
YoY Change -47.61% -75.76%
% of Operating Profit 1.3% 9.42%
Other Income/Expense, Net $4.380K
YoY Change 9.5%
Pretax Income $111.4K $281.3K $80.25K
YoY Change 124.21% 250.58% -3.41%
Income Tax $81.70K $92.81K $30.19K
% Of Pretax Income 73.35% 32.99% 37.62%
Net Earnings $29.69K $188.5K $50.05K
YoY Change 54.96% 276.61% -13.66%
Net Earnings / Revenue 14.5% 108.62% 31.12%
Basic Earnings Per Share $0.10
Diluted Earnings Per Share $15.28K $97.05K $25.77K
COMMON SHARES
Basic Shares Outstanding 1.942M 1.942M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.913M $7.891M $6.952M
YoY Change 13.59% 13.5% 9.27%
Cash & Equivalents $7.410M $7.388M $5.256M
Short-Term Investments $502.8K $502.8K $1.696M
Other Short-Term Assets $35.41K $51.98K $53.85K
YoY Change 306.54% -3.47% -37.64%
Inventory
Prepaid Expenses
Receivables $50.74K $60.21K $80.21K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.999M $8.003M $7.086M
YoY Change 13.09% 12.93% 8.02%
LONG-TERM ASSETS
Property, Plant & Equipment $9.056M $9.085M $9.235M
YoY Change -2.03% -1.63% -0.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $9.056M $9.085M $9.235M
YoY Change -2.03% -1.63% -0.03%
TOTAL ASSETS
Total Short-Term Assets $7.999M $8.003M $7.086M
Total Long-Term Assets $9.056M $9.085M $9.235M
Total Assets $17.06M $17.09M $16.32M
YoY Change 4.53% 4.69% 3.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $111.1K $112.1K $86.37K
YoY Change 29.77% -34.59%
Accrued Expenses
YoY Change
Deferred Revenue $150.1K $201.7K $248.6K
YoY Change -35.13% -18.85% 162.41%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $261.2K $324.0K $366.5K
YoY Change -23.66% -11.61% 61.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $261.2K $324.0K $366.5K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $448.9K $511.6K $554.2K
YoY Change -15.28% -7.68% 33.72%
SHAREHOLDERS EQUITY
Retained Earnings $16.55M $16.52M $15.71M
YoY Change 5.21% 5.15% 2.5%
Common Stock $59.34K $59.34K $59.34K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares
Shareholders Equity $16.61M $16.58M $15.77M
YoY Change
Total Liabilities & Shareholders Equity $17.06M $17.09M $16.32M
YoY Change 4.53% 4.69% 3.31%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $29.69K $188.5K $50.05K
YoY Change 54.96% 276.61% -13.66%
Depreciation, Depletion And Amortization $540.00 $507.00 $1.326K
YoY Change -32.5% -61.76% 161.54%
Cash From Operating Activities -$199.8K $130.00 $84.50K
YoY Change 449.3% -99.85% -33.24%
INVESTING ACTIVITIES
Capital Expenditures -$960.00 -$7.600K $0.00
YoY Change -89.7% -100.0%
Acquisitions
YoY Change
Other Investing Activities $222.7K $265.2K $1.604M
YoY Change -82.23% -83.47% 598.74%
Cash From Investing Activities $221.7K $257.6K $1.604M
YoY Change -82.17% -83.95% 612.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -199.8K 130.0 84.50K
Cash From Investing Activities 221.7K 257.6K 1.604M
Cash From Financing Activities
Net Change In Cash 21.94K 257.7K 1.689M
YoY Change -98.18% -84.74% 380.35%
FREE CASH FLOW
Cash From Operating Activities -$199.8K $130.00 $84.50K
Capital Expenditures -$960.00 -$7.600K $0.00
Free Cash Flow -$198.8K $7.730K $84.50K
YoY Change 635.01% -90.85% -35.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1942495
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000
CY2021Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1942495
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1942495
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1942495
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1942495
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 pure
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7387932 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6463255 USD
CY2021Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
502794 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
502595 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60214 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
98515 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51978 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8711 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
8002918 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
7073076 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9085213 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9243621 USD
CY2021Q3 us-gaap Assets
Assets
17088131 USD
CY2020Q4 us-gaap Assets
Assets
16316697 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
112080 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
110786 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
201739 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
231409 USD
CY2021Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
10146 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
323965 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
342195 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
187664 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
187664 USD
CY2021Q3 us-gaap Liabilities
Liabilities
511629 USD
CY2020Q4 us-gaap Liabilities
Liabilities
529859 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
59335 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
59335 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16517167 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15727503 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
16576502 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15786838 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17088131 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16316697 USD
CY2021Q3 us-gaap Revenues
Revenues
173546 USD
CY2020Q3 us-gaap Revenues
Revenues
160842 USD
us-gaap Revenues
Revenues
539729 USD
us-gaap Revenues
Revenues
529930 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
141136 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
121426 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
392538 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
457637 USD
us-gaap Depreciation
Depreciation
1793 USD
CY2021Q3 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
261316 USD
CY2021Q3 us-gaap Depreciation
Depreciation
507 USD
CY2020Q3 us-gaap Depreciation
Depreciation
1326 USD
us-gaap Depreciation
Depreciation
1517 USD
CY2020Q3 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
41331 USD
us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
851582 USD
us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
295238 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
-104154 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
87511 USD
us-gaap Costs And Expenses
CostsAndExpenses
-419129 USD
us-gaap Costs And Expenses
CostsAndExpenses
196552 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
277700 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
73331 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
958858 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
333378 USD
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3622 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
6914 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
13075 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
55170 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
281322 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
80245 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
971933 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
388548 USD
CY2021Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
92813 USD
CY2020Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
30191 USD
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
182269 USD
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
68322 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
92813 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30191 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
182269 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68322 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
188509 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
50054 USD
us-gaap Net Income Loss
NetIncomeLoss
789664 USD
us-gaap Net Income Loss
NetIncomeLoss
320226 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.10
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.41
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.16
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1942495
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1942495
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1942495
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1942495
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
16387993 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
188509 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
16576502 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
15717627 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
50054 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
15767681 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15786838 USD
us-gaap Net Income Loss
NetIncomeLoss
789664 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
16576502 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
15447455 USD
us-gaap Net Income Loss
NetIncomeLoss
320226 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
15767681 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
30000 USD
us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
19170 USD
us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0 USD
us-gaap Net Income Loss
NetIncomeLoss
789664 USD
us-gaap Net Income Loss
NetIncomeLoss
320226 USD
us-gaap Depreciation
Depreciation
1517 USD
us-gaap Depreciation
Depreciation
1793 USD
us-gaap Depletion
Depletion
534 USD
us-gaap Depletion
Depletion
683 USD
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
851582 USD
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
295238 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1503 USD
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-14204 USD
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-8455 USD
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-18230 USD
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
139117 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-63893 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
176539 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1985767 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3489163 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
199 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3708 USD
ckx Payments Of Reforesting Timber Costs
PaymentsOfReforestingTimberCosts
17650 USD
us-gaap Payments To Acquire Land
PaymentsToAcquireLand
4063 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1010482 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
299441 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
988570 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1799129 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
924677 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1975668 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6463255 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3280289 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7387932 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5255957 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
171423 USD
us-gaap Depreciation
Depreciation
1793 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><i>Concentration of Credit Risk</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company maintains its cash balances in <em style="font: inherit;">seven</em> financial institutions. The amount on deposit in each financial institution is insured by the Federal Deposit Insurance Corporation up to <em style="font: inherit;">$250,000.</em> The Company has <em style="font: inherit;">not</em> experienced any losses in such accounts and management believes the Company is <em style="font: inherit;">not</em> exposed to any significant credit risk on its cash balances.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9167200 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9324091 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
81987 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
80470 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9085213 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9243621 USD
us-gaap Depreciation
Depreciation
1517 USD
us-gaap Depletion
Depletion
534 USD
us-gaap Depletion
Depletion
683 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
21713 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9321 USD

Files In Submission

Name View Source Status
0001437749-21-025473-index-headers.html Edgar Link pending
0001437749-21-025473-index.html Edgar Link pending
0001437749-21-025473.txt Edgar Link pending
0001437749-21-025473-xbrl.zip Edgar Link pending
ckx-20210930.xsd Edgar Link pending
ckx-20210930_cal.xml Edgar Link unprocessable
ckx-20210930_def.xml Edgar Link unprocessable
ckx-20210930_lab.xml Edgar Link unprocessable
ckx-20210930_pre.xml Edgar Link unprocessable
ckx20210930_10q.htm Edgar Link pending
ckx20210930_10q_htm.xml Edgar Link completed
ex_301269.htm Edgar Link pending
ex_301270.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending